Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Asset Utilization Ratio: 2022-2025

Historic Asset Utilization Ratio for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Sep 2025 value amounting to 0.01.

  • Centessa Pharmaceuticals' Asset Utilization Ratio rose 171.07% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year increase of 171.07%. This contributed to the annual value of -0.02 for FY2024, which is 226.42% down from last year.
  • Centessa Pharmaceuticals' Asset Utilization Ratio amounted to 0.01 in Q3 2025, which was up 3.36% from 0.01 recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.01 for Q3 2025, and its period low was -0.03 during Q1 2024.
  • In the last 3 years, Centessa Pharmaceuticals' Asset Utilization Ratio had a median value of -0.02 in 2024 and averaged -0.01.
  • As far as peak fluctuations go, Centessa Pharmaceuticals' Asset Utilization Ratio plummeted by 70.44% in 2023, and later spiked by 171.07% in 2025.
  • Over the past 4 years, Centessa Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at -0.02 in 2022, then plummeted by 70.44% to -0.03 in 2023, then surged by 36.68% to -0.02 in 2024, then skyrocketed by 171.07% to 0.01 in 2025.
  • Its last three reported values are 0.01 in Q3 2025, 0.01 for Q2 2025, and 0.01 during Q1 2025.